Dai, J., Xu, T., Li, L., Fang, M., Lin, J., Cao, J., . . . Si, L. Atezolizumab plus bevacizumab in patients with unresectable or metastatic mucosal melanoma: 3‐year survival update and multi‐omics analysis. Wiley.
Chicago Style (17th ed.) CitationDai, Jie, et al. Atezolizumab Plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: 3‐year Survival Update and Multi‐omics Analysis. Wiley.
MLA (9th ed.) CitationDai, Jie, et al. Atezolizumab Plus Bevacizumab in Patients with Unresectable or Metastatic Mucosal Melanoma: 3‐year Survival Update and Multi‐omics Analysis. Wiley.
Warning: These citations may not always be 100% accurate.